NASDAQ: CYTK · Health Technology
Which UK funds hold Cytokinetics, Incorporated (CYTK)?
Cytokinetics, Incorporated (CYTK) is among the ten largest holdings of 1 UK fund Fundology covers, according to the holdings each fund publishes. The largest weight is 0.30%, in VRSG (Vanguard Russell 2000 U.S. Small-Cap UCITS ETF), as of 30/09/2026. In all, 28 funds list it among their published holdings. 3 swap-based funds also list Cytokinetics, Incorporated (CYTK) in the substitute baskets they hold as collateral; they track different indices through swaps and are not counted as holders.
UK funds that hold Cytokinetics, Incorporated
Funds where it is one of the ten largest holdings, largest weight first. A weight is the share of the fund’s money in this company.
| Fund | Weight in the fund | Holdings as of |
|---|---|---|
| VRSG · Vanguard Russell 2000 U.S. Small-Cap UCITS ETFIE000GTBEXG4 · one portfolio, 2 share classes | 0.30% |
Holdings dates differ by fund
Funds that hold it further down
27 more funds list Cytokinetics, Incorporated below their ten largest holdings.
Create a free account to see every fund that holds this company, at any weight
Sign-up takes an email address. There is no card to enter and nothing to pay.
About Cytokinetics, Incorporated
Cytokinetics, Incorporated is listed on NASDAQ under the symbol CYTK, in the health technology sector. Its market value was about $7.8bn (in US dollars) on 13/11/2026.
A fund’s weight in a company is the share of the fund’s money held in that company’s shares. A weight of 5% in a fund worth £1 billion is about £50 million. Index funds hold companies in proportion to their size in the index, so the largest companies appear in many funds at similar weights.
The list above is drawn from the funds’ published holdings, each dated, and names the funds where Cytokinetics, Incorporated is one of the ten largest holdings — the part of every fund page open to anyone. Some funds publish only their largest ten, so a fund can hold Cytokinetics, Incorporated without it appearing in any list here. When two funds both hold the same large companies, owning both can be closer to owning one than it looks: the comparison page measures that overlap when both funds publish enough of their holdings.
Share price
- Latest price
- $55.69
- −0.85%on the day
- 52-week range
- $53.55–$88.31
- Price change, 1 year
- −14.7%
- Price change, this year
- −11.8%
- Market value
- $7.8bn
- Dividend yield (12 months)
- 0.00%
As of , at least 15 min delayed